Merck & Company Inc (MRK) Insider Trading
- $76,196,930.25
- $746,098,067.04
- Feb. 9, 2026
- Kenneth C Frazier
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| May 10, 2021 | EVP | 19,324 | $78.32 | Sell | $1,513,455.68 | |
| Oct. 5, 2020 | CFO | 251,273 | $81.03 | Sell | $20,360,651.19 | |
| Aug. 13, 2020 | Insider | 10,380 | $83.01 | Sell | $861,643.80 | |
| Aug. 5, 2020 | EVP | 18,876 | $81.55 | Sell | $1,539,337.80 | |
| July 17, 2020 | EVP | 36,285 | $80.00 | Sell | $2,902,800.00 | |
| May 7, 2020 | Director | 5,000 | $76.02 | Sell | $380,100.00 | |
| Jan. 13, 2020 | EVP | 102,073 | $89.34 | Sell | $9,119,201.82 | |
| Aug. 9, 2019 | EVP | 6,427 | $85.09 | Sell | $546,873.43 | |
| June 25, 2019 | CFO | 216,718 | $85.43 | Sell | $18,514,218.74 | |
| May 7, 2019 | EVP | 25,000 | $77.73 | Sell | $1,943,250.00 | |
| May 3, 2019 | EVP | 35,000 | $80.00 | Sell | $2,800,000.00 | |
| April 8, 2019 | Major Shareholder | 4,121,683 | $16.00 | Buy | $65,946,928.00 | |
| March 25, 2019 | EVP | 192,572 | $82.38 | Sell | $15,864,081.36 | |
| March 20, 2019 | Chairman | 192,736 | $82.05 | Sell | $15,813,988.80 | |
| March 13, 2019 | Chairman | 18,725 | $82.00 | Sell | $1,535,450.00 | |
| March 5, 2019 | Chairman | 20,105 | $82.00 | Sell | $1,648,610.00 | |
| Feb. 22, 2019 | CEO | 53,961 | $80.02 | Sell | $4,317,959.22 | |
| Feb. 19, 2019 | Chairman | 135,613 | $80.03 | Sell | $10,853,108.39 | |
| Feb. 15, 2019 | CEO | 92,913 | $80.03 | Sell | $7,435,827.39 | |
| Feb. 14, 2019 | VP | 64,662 | $78.96 | Sell | $5,105,711.52 | |
| Feb. 13, 2019 | Director | 5,000 | $78.71 | Sell | $393,550.00 | |
| Feb. 12, 2019 | Insider | 73,727 | $78.62 | Sell | $5,796,416.74 | |
| Feb. 8, 2019 | Director | 3,052 | $77.22 | Sell | $235,675.44 | |
| Feb. 5, 2019 | Chairman | 231,566 | $78.08 | Sell | $18,080,673.28 | |
| Feb. 4, 2019 | Director | 10,000 | $75.96 | Sell | $759,600.00 | |
| Nov. 8, 2018 | Insider | 225,443 | $75.27 | Sell | $16,969,094.61 | |
| Nov. 7, 2018 | EVP | 36,218 | $75.14 | Sell | $2,721,420.52 | |
| Nov. 1, 2018 | EVP | 277,879 | $73.81 | Sell | $20,510,248.99 | |
| Oct. 31, 2018 | SVP | 47,036 | $74.33 | Sell | $3,496,185.88 | |
| Oct. 30, 2018 | EVP | 25,467 | $72.00 | Sell | $1,833,624.00 | |
| Oct. 2, 2018 | Chairman | 279,850 | $72.07 | Sell | $20,168,789.50 | |
| Oct. 1, 2018 | Major Shareholder | 666,666 | $15.00 | Buy | $9,999,990.00 | |
| Sept. 18, 2018 | Chairman | 279,851 | $70.08 | Sell | $19,611,958.08 | |
| Sept. 17, 2018 | EVP | 107,360 | $70.18 | Sell | $7,534,524.80 | |
| Aug. 3, 2018 | Insider | 29,208 | $65.20 | Sell | $1,904,361.60 | |
| Aug. 2, 2018 | VP | 5,000 | $65.01 | Sell | $325,050.00 | |
| July 31, 2018 | Chairman | 228,091 | $65.00 | Sell | $14,825,915.00 | |
| June 18, 2018 | EVP | 134,094 | $61.00 | Sell | $8,179,734.00 | |
| May 15, 2018 | EVP | 9,972 | $59.66 | Sell | $594,929.52 | |
| April 16, 2018 | Insider | 24,000 | $58.00 | Sell | $1,392,000.00 | |
| Feb. 9, 2018 | Director | 5,000 | $53.57 | Sell | $267,850.00 | |
| Jan. 16, 2018 | Insider | 60,000 | $61.63 | Sell | $3,697,800.00 | |
| Jan. 16, 2018 | EVP | 12,500 | $61.63 | Sell | $770,375.00 | |
| Jan. 12, 2018 | Insider | 5,000 | $58.00 | Sell | $290,000.00 | |
| Nov. 8, 2017 | Director | 5,000 | $56.20 | Sell | $281,000.00 | |
| May 12, 2017 | Director | 5,000 | $63.54 | Sell | $317,700.00 | |
| April 3, 2017 | EVP | 53,850 | $63.48 | Sell | $3,418,398.00 | |
| Feb. 8, 2017 | Director | 5,000 | $64.42 | Sell | $322,100.00 | |
| Feb. 6, 2017 | Director | 5,000 | $64.51 | Sell | $322,550.00 | |
| Feb. 3, 2017 | Director | 5,000 | $63.42 | Sell | $317,100.00 |
Insiders are both buying and selling Merck & Company Inc stock.
The insider traders at Merck & Company Inc are: Kenneth C Frazier, Richard R Deluca, Adam H Schechter, Steven Mizell, Sanat Chattopadhyay, Robert M Davis, Weir Mirian M Graddick, Wendell P Weeks, Julie L Gerberding, Frank Clyburn, Rita A Karachun, Johannes Jacobus Oosthuizen, Willie A Deese, Bruce N Kuhlik, Clark Golestani, Rochelle B Lazarus, Caroline Litchfield, Marjorie Taylor Greene, Merck & Co., Inc., Michael J Holston, Chirfi Guindo, Adele D Ambrose, Kenneth Frazier, Adam Schechter, Thomas H Glocer, Joseph Romanelli, Dalton E Smart III, Willie Deese, Michael J. Holston, Adele D. Ambrose, Ashley Watson, Bridgette Heller, Bridgette P Heller, Bruce Kuhlik, Cristal N Downing, C Robert Kidder, David Michael Williams, Dean Y Li, Inge G Thulin, Jennifer Zachary, John Canan, John James, Julie L. Gerberding, Kenneth C. Frazier, Leslie A Brun, Patricia F Russo, Peter C Wendell, Peter C. Wendell, Peter Wendell, Rita A. Karachun, Roger M Perlmutter, Thomas R Cech, Weir Mirian M. Graddick, and Wendell P. Weeks
The most active insider trader at Merck & Company Inc is Kenneth C Frazier with 26 trades.
Kenneth C Frazier has sold the most Merck & Company Inc stock with a total value of $294,584,131.58.
Merck & Co., Inc. has bought the most Merck & Company Inc stock with a total value of $141,893,846.00.
The most recent insider trade for Merck & Company Inc was on Feb. 9, 2026.
The single biggest insider buy for Merck & Company Inc was from Merck & Co., Inc. with a total value of $65,946,928.00 on April 8, 2019.
The single biggest insider sell for Merck & Company Inc was from Kenneth C Frazier with a total value of $54,610,851.06 on Nov. 9, 2021.